Patents by Inventor Sorif Uddin

Sorif Uddin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of for treating inflammatory conditions
    Patent number: 10960032
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Grant
    Filed: December 3, 2019
    Date of Patent: March 30, 2021
    Assignee: SCHWEIZERISCHES FORSCHUNGSINSTITUT FÜR HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • USE OF AKKERMANSIA MUCINIPHILA FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20200164003
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Application
    Filed: December 3, 2019
    Publication date: May 28, 2020
    Applicant: SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • Use of for treating inflammatory conditions
    Patent number: 10537597
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Grant
    Filed: October 5, 2016
    Date of Patent: January 21, 2020
    Assignee: Schweizerisches Forschungsinstitut Fur Hochgebrigsklima Und Medizin In Davos
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin
  • USE OF AKKERMANSIA MUCINIPHILA FOR TREATING INFLAMMATORY CONDITIONS
    Publication number: 20180296613
    Abstract: The invention relates to use of Akkermansia muciniphila, a mucin-degrading bacterial species found in the human gut, for treating undesirable inflammatory activity not caused by any metabolic disorder and/or obesity, especially for example undesirable airway inflammatory activity as seen with asthma.
    Type: Application
    Filed: October 5, 2016
    Publication date: October 18, 2018
    Applicant: SCHWEIZERISCHES FORSCHUNGSINSTITUT FUR HOCHGEBRIGSKLIMA UND MEDIZIN IN DAVOS
    Inventors: Liam O'Mahony, Cezmi A. Akdis, David Michalovich, Edith M. Hessel, James R. Brown, David N. Mayhew, Sorif Uddin